Glycerylphosphorylcholine: Clinical Trials

5 trials of Glycerylphosphorylcholine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 1 completed. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 4, Completed 1

Follow Glycerylphosphorylcholine: new trials by email Literature Review of Glycerylphosphorylcholine trials Research Report on Glycerylphosphorylcholine

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
Choline Alfoscerate 400mg, Placebo - Alzheimer Disease
Phase 4UnknownDaewoong Bio Inc.6302022-01-202024-03-21
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
Choline Alfoscerate, Placebo - Mild Cognitive Impairment
Phase 4UnknownChong Kun Dang Pharmaceutical4182021-09-302021-09-20
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients
Choline Alfoscerate 400mg, Placebo of Choline Alfoscerate 400mg - Vascular Cognitive Impairment
Phase 4UnknownChong Kun Dang Pharmaceutical4182021-09-012021-09-20
A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients
Choline alfoscerate, Placebo - Alzheimer Disease
Phase 4UnknownDaewoong Pharmaceutical Co. LTD.1282015-07-012016-11-02
The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia
choline alfoscerate, placebo (for choline alphoscerate) - Cognitive Impairment, Stroke
Phase 4CompletedSeoul National University Hospital2222010-11-012013-10-14

Conditions studied

Alzheimer Disease (2)  ·  Cognitive Dysfunction (2)  ·  Stroke (1)

Sponsors

Chong Kun Dang Pharmaceutical (2)  ·  Daewoong Bio Inc. (1)  ·  Daewoong Pharmaceutical Co. LTD. (1)  ·  Seoul National University Hospital (1)

Countries

South Korea (5)

Top investigators

JaeHong Lee, MD (1)  ·  Sun U Kwon, MD, PhD (1)